GUSBP11, which was correlated with a poor prognosis in EOC (Table 3 and Table 4, and Figure 4), was upregulated in plasma from gastric cancer patients in comparison with healthy individuals [111]. This evidence concerns the gene GUSBP11 and gastric cancer.